Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer

Clinical trial NCT00706030 · COMPLETED

Trial details

NCT number: NCT00706030
Sponsor: Puma Biotechnology, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Advanced Malignant Solid Tumors

Start date: 2008-04-29
Primary completion: 2009-10-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.